Nathan Ford

24.9k total citations · 4 hit papers
306 papers, 15.3k citations indexed

About

Nathan Ford is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Nathan Ford has authored 306 papers receiving a total of 15.3k indexed citations (citations by other indexed papers that have themselves been cited), including 210 papers in Infectious Diseases, 115 papers in Epidemiology and 64 papers in Virology. Recurrent topics in Nathan Ford's work include HIV/AIDS Research and Interventions (187 papers), HIV/AIDS drug development and treatment (75 papers) and HIV Research and Treatment (64 papers). Nathan Ford is often cited by papers focused on HIV/AIDS Research and Interventions (187 papers), HIV/AIDS drug development and treatment (75 papers) and HIV Research and Treatment (64 papers). Nathan Ford collaborates with scholars based in South Africa, Switzerland and United Kingdom. Nathan Ford's co-authors include Edward J. Mills, Katharina Kranzer, Darshini Govindasamy, Marco Vitória, Meg Doherty, Helen Schneider, Mike Callaghan, Alexandra Calmy, Jean B. Nachega and Piero Olliaro and has published in prestigious journals such as Science, New England Journal of Medicine and The Lancet.

In The Last Decade

Nathan Ford

298 papers receiving 14.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Drug development for neglected diseases: a deficient market and a public-health policy failure

2002 546 citations Nathan Ford et al. profile →
A systematic review of task- shifting for HIV treatment and care in Africa

2010 485 citations Nathan Ford, Helen Schneider et al. profile →
Risk factors, barriers and facilitators for linkage to antiretroviral therapy care

2012 359 citations Nathan Ford et al. profile →
Patient-Reported Barriers to Adherence to Antiretroviral Therapy: A Systematic Review and Meta-Analysis

2016 353 citations Zara Shubber, Edward J. Mills et al. PLoS Medicine profile →

Peers

Countries citing papers authored by Nathan Ford

Since Specialization

Citations

This map shows the geographic impact of Nathan Ford's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nathan Ford with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nathan Ford more than expected).

Fields of papers citing papers by Nathan Ford

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nathan Ford. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nathan Ford. The network helps show where Nathan Ford may publish in the future.

Co-authorship network of co-authors of Nathan Ford

This figure shows the co-authorship network connecting the top 25 collaborators of Nathan Ford. A scholar is included among the top collaborators of Nathan Ford based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nathan Ford. Nathan Ford is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	HIV post‐exposure prophylaxis in community settings and by lay health workers or through task sharing: a systematic review of effectiveness, case studies, values and preferences, and costs 2025 ·Journal of the International AIDS Society ·Caitlin E. Kennedy, (unknown), Ping Teresa Yeh, Michelle Rodolph, Nathan Ford, H Schmidt, Robin Schaefer, Rachel Baggaley, Virginia Macdonald	0
2	Effect of same-day HIV treatment initiation (SDI) on 1-year outcomes in low- and middle-income countries: systematic review and meta-analysis of randomised trials 2025 ·BMJ Global Health ·(unknown), (unknown), (unknown), Alain Amstutz, Sydney Rosen, Alana T. Brennan, Mhairi Maskew, Serena P. Koenig, Nancy Dorvil, Elvin Geng, Tracy R. Glass, Nathan Ford, Niklaus Daniel Labhardt, Stefan Schandelmaier	1
3	Biomarkers to predict or measure steroid resistance in idiopathic nephrotic syndrome: A systematic review 2025 ·PLoS ONE ·Carl May, Nathan Ford, Gavin I. Welsh, Moin A. Saleem	2
4	Understanding effective post‐test linkage strategies for HIV prevention and care: a scoping review 2024 ·Journal of the International AIDS Society ·Beatrice Wamuti, Muhammad S. Jamil, Nandi Siegfried, Nathan Ford, Rachel Baggaley, Cheryl Johnson, Peter Cherutich	1
5	Prevalence of Drug Resistance Associated Substitutions in Persons With Chronic Hepatitis C Infection and Virological Failure Following Initial or Re-treatment With Pan-genotypic Direct-Acting Antivirals: A Systematic Review and Meta-analysis 2024 ·Clinical Infectious Diseases ·(unknown), Philippa Easterbrook, (unknown), Nathan Ford, William L. Irving, Philippa C. Matthews, Marco Vitória, Chris Duncombe, Amalia Girón‐Callejas, Suzanne M. McCluskey, Olufunmilayo Lesi, S. Tchamgoué, Rachel Halford, (unknown), Emma C. Thomson, Geoff Dusheiko, Michael R. Jordan	1
6	Features and global impact of invasive fungal infections caused by Pneumocystis jirovecii: A systematic review to inform the World Health Organization fungal priority pathogens list 2024 ·Medical Mycology ·Brendan McMullan, Hannah Yejin Kim, Ana Alastruey‐Izquierdo, Evelina Tacconelli, Aiken Dao, Rita Oladele, (unknown), Nelesh P. Govender, Jong Hee Shin, Jutta Heim, Nathan Ford, Benedikt Huttner, Marcelo Galas, (unknown), Valeria Gigante, Hatim Sati, Jan‐Willem C. Alffenaar, C. Orla Morrissey, Justin Beardsley	3
7	Reasons for disengagement from antiretroviral care in the era of “Treat All” in low‐ or middle‐income countries: a systematic review 2024 ·Journal of the International AIDS Society ·Rachael M. Burke, Hannah M. Rickman, (unknown), Peter Ehrenkranz, Augustine Choko, Nathan Ford	10
8	Interventions to reduce deaths in people living with HIV admitted to hospital in low- and middle-income countries: A systematic review 2023 ·SHILAP Revista de lepidopterología ·Rachael M. Burke, (unknown), (unknown), Marriott Nliwasa, Ankur Gupta‐Wright, Katherine Fielding, Nathan Ford, Peter MacPherson, Elizabeth L. Corbett	7
9	Use of indirect evidence from HIV self-testing to inform the WHO hepatitis C self-testing recommendation 2023 ·BMJ Global Health ·Virginia A. Fonner, Niklas Luhmann, Nandi Siegfried, Cheryl Johnson, Rachel Baggaley, Nathan Ford, Muhammad S. Jamil	4
10	Strengthening implementation guidelines for HIV service delivery: Considerations for future evidence generation and synthesis 2023 ·PLoS Medicine ·Ingrid Eshun‐Wilson, Nathan Ford, Aaloke Mody, Laura K. Beres, Sheree Schwartz, Stefan Baral, Elvin Geng	2
11	Evaluation of HIV treatment outcomes with reduced frequency of clinical encounters and antiretroviral treatment refills: A systematic review and meta-analysis 2022 ·PLoS Medicine ·(unknown), (unknown), Ryan Thompson, Nathan Ford, Sheree Schwartz, Laura K. Beres, Aaloke Mody, Stefan Baral, Elvin Geng, Ingrid Eshun‐Wilson	8
12	The revolving door of HIV care: Revising the service delivery cascade to achieve the UNAIDS 95-95-95 goals 2021 ·PLoS Medicine ·Peter Ehrenkranz, Sydney Rosen, Andrew Boulle, Jeffrey W. Eaton, Nathan Ford, Matthew P. Fox, Anna Grimsrud, Brian Rice, Izukanji Sikazwe, Charles B. Holmes	88
13	Effects of community-based antiretroviral therapy initiation models on HIV treatment outcomes: A systematic review and meta-analysis 2021 ·PLoS Medicine ·Ingrid Eshun‐Wilson, Ajibola Awotiwon, (unknown), (unknown), Nathan Ford, Sheree Schwartz, Stefan Baral, Elvin Geng	27
14	Trends in CD4 and viral load testing 2005 to 2018: multi‐cohort study of people living with HIV in Southern Africa 2020 ·Journal of the International AIDS Society ·Elizabeth Zaniewski, (unknown), Frédérique Chammartin, Nicola Maxwell, Mary‐Ann Davies, Jonathan Euvrard, (unknown), Samuel Bosomprah, Sam Phiri, Frank Tanser, (unknown), Josephine Muhairwe, Geoffrey Fatti, Hans Prozesky, Robin Wood, Nathan Ford, Matthew P. Fox, Matthias Egger	28
15	Retention and mortality on antiretroviral therapy in sub‐Saharan Africa: collaborative analyses of HIV treatment programmes 2018 ·Journal of the International AIDS Society ·Andreas D. Haas, Elizabeth Zaniewski, Nanina Anderegg, Nathan Ford, Matthew P. Fox, Michael J. Vinikoor, François Dabis, Denis Nash, Jean d’Amour Sinayobye, (unknown), Aristophane Tanon, Armel Poda, Adebola Adedimeji, Andrew Edmonds, Mary‐Ann Davies, Matthias Egger, (unknown)	85
16	A pragmatic approach to monitor and evaluate implementation and impact of differentiated ART delivery for global and national stakeholders 2018 ·Journal of the International AIDS Society ·Peter Ehrenkranz, (unknown), Wafaa El‐Sadr, Ade Fakoya, Nathan Ford, Anna Grimsrud, Kate Lockwood Harris, (unknown), Daniel Low‐Beer, Sadhna Patel, Miriam Rabkin, William Reidy, (unknown), George K. Siberry, (unknown), Isaac Zulu, Irum Zaidi	14
17	Stable patients and patients with advanced disease: consensus definitions to support sustained scale up of antiretroviral therapy 2016 ·Tropical Medicine & International Health ·Greer Waldrop, Meg Doherty, Marco Vitória, Nathan Ford	47
18	Patient-Reported Barriers to Adherence to Antiretroviral Therapy: A Systematic Review and Meta-Analysis breakdown → 2016 ·PLoS Medicine ·Zara Shubber, Edward J. Mills, Jean B. Nachega, Rachel Vreeman, Marcelo Araújo de Freitas, Peter Bock, Sabin Nsanzimana, Martina Penazzato, (unknown), Meg Doherty, Nathan Ford	353
19	Ethics of conducting research in conflict settings 2009 ·Conflict and Health ·Nathan Ford, Edward J. Mills, Rony Zachariah, Ross Upshur	108
20	Sustainability of long-term treatment in a rural district : the Lusikisiki model of decentralised HIV / AIDS care : HIV management 2006 ·Southern African Journal of HIV Medicine ·Nathan Ford, Hermann Reuter, (unknown), Helen Schneider, Helmuth Reuter	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact